Impact of Immune response-associated gene polymorphisms on tumor response in rectal cancer patients treated with capecitabine +/- oxaliplatine and radiation in the ACCORD-12/PRODIGE-2 phase III trialB. Valerie, Pierre Laurent‐Puig, Nathalie Chaput et al.|Annals of Oncology|2017Cited by 0